Clinical Trial Update: Preventing Stem Cell Transplant Complications With a Blood Separator Machine [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating a blood separator machine to prevent complications after stem cell transplant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia B-all
• Acute Myeloid Leukemia
• Lymphoma Non-hodgkin
• Myelodysplastic Syndrome
• Myeloproliferative Disorder

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: MDS (Myelodysplastic Syndrome), Myeloproliferative Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-05-26